Other
Interest Paid, Net
Pfizer Interest Paid, Net decreased by 70.1% to $293.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 17.0%, from $353.00M to $293.00M. Over 4 years (FY 2021 to FY 2025), Interest Paid, Net shows an upward trend with a 16.9% CAGR.
Analysis
StatementIncome Statement
SectionOther
First reportedQ1 2013
Last reportedQ1 2026May 5, 2026
Metric ID:
ms_interest_paid_netHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $353.00M | $407.00M | $262.00M | $453.00M | $318.00M | $350.00M | $321.00M | $419.00M | $402.00M | $332.00M | $1.06B | $415.00M | $1.14B | $280.00M | $1.39B | $353.00M | $1.13B | $275.00M | $981.00M | $293.00M |
| QoQ Change | — | +15.3% | -35.6% | +72.9% | -29.8% | +10.1% | -8.3% | +30.5% | -4.1% | -17.4% | +219.9% | -60.9% | +174.2% | -75.4% | +397.9% | -74.7% | +220.1% | -75.7% | +256.7% | -70.1% |
| YoY Change | — | — | — | — | -9.9% | -14.0% | +22.5% | -7.5% | +26.4% | -5.1% | +230.8% | -1.0% | +183.1% | -15.7% | +31.3% | -14.9% | -0.7% | -1.8% | -29.6% | -17.0% |
Range$262.00M – $1.39B
CAGR-3.8%
Avg YoY Growth+23.6%
Median YoY Growth-3.5%
Interest Paid, Net at Other Companies
Frequently Asked Questions
- What is Pfizer's interest paid, net?
- Pfizer (PFE) reported interest paid, net of $293.00M in Q1 2026.
- How has Pfizer's interest paid, net changed year-over-year?
- Pfizer's interest paid, net decreased by 17.0% year-over-year, from $353.00M to $293.00M.
- What is the long-term trend for Pfizer's interest paid, net?
- Over 4 years (2021 to 2025), Pfizer's interest paid, net has grown at a 16.9% compound annual growth rate (CAGR), from $1.47B to $2.74B.